Cargando…
Review of the literature on combined oral contraceptives and cancer
Millions of women have given preference to the use of combined oral contraceptives (COCs) since its introduction in the 1960s. Both oestrogens and progestogens can regulate proliferation and it is plausible these effects may contribute to carcinogenesis. We aimed to review the accumulated knowledge...
Autores principales: | Kamani, Mustafa, Akgor, Utku, Gültekin, Murat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377820/ https://www.ncbi.nlm.nih.gov/pubmed/36072240 http://dx.doi.org/10.3332/ecancer.2022.1416 |
Ejemplares similares
-
Using a pessary during radiotherapy in reducible pelvic organ prolapse and vaginal cancer: a case report and review of the literature
por: Gultekin, Melis, et al.
Publicado: (2020) -
Anxiety, depression and concerns of pregnant women during the COVID-19 pandemic
por: Akgor, Utku, et al.
Publicado: (2021) -
Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
por: Nappi, Rossella E, et al.
Publicado: (2014) -
Breast cancer and combined oral contraceptives.
por: Shelton, J. D.
Publicado: (1990) -
Transdermal delivery of combined hormonal contraception: a review of the current literature
por: Galzote, Rosanna M, et al.
Publicado: (2017)